US/UK/Canada

Share

Links

Quotes

In the past, resistance mechanisms were usually thought of as static. Our study demonstrates, conversely, that a binary designation of resistance may oversimplify cancer’s true biology. These genetic mutations can fluctuate over time, and some patients can harbor more than one mutation.
Zofia Piotrowska, MD, lead author of the study
In an era where cancer treatment is increasingly personalized to the biology of each individual patient, our findings highlight the importance of molecular testing and the need for improved, noninvasive methods for serial testing.
Zofia Piotrowska, MD
In the past year, the Vice President’s moonshot initiative has brought critical attention to the need for greater collaboration and innovation in cancer research, and we are invigorated at the prospect of radiation oncology being an instrumental component of future progress. Moving forward, we must maintain the focus on advancing both the science and practice of cancer care while aligning our efforts to move Congress to authorize the $700 million requested by the President for cancer research initiatives. Substantial, predictable financial support is essential to sustain the fight to eradicate cancer.
Bruce G. Haffty, MD, FASTRO, past Chair of ASTRO’s Board of Directors
The goal of ASTRO’s 2016 Annual Meeting is to highlight the latest scientific and technological advances while emphasizing the importance of radiation oncology in providing value to cancer patients through cure and palliation.
ASTRO President David C. Beyer, MD, FASTRO
Pick a time period -
Tags ( Active)

ASTRO leadership visits White House to participate in Vice President’s cancer moonshot event

Society continues to encourage inclusion of radiation oncology in strategic planning for the initiative and applauds collaborative efforts with industry and governmentWASHINGTON, D.C., October 18, 2016 – Leadership from the American Society for Radiation Oncology (ASTRO) participated in an event at the White House yesterday hosted by Vice President Joe Biden, who released a report outlining the Cancer Moonshot Initiative’s (CMI) progress to date and roadmap for its four remaining years. Former Chair of ASTRO’s Board of Directors Bruce G. Haffty, MD, FASTRO, attended on behalf of the Society

Radiation oncologists meet with members of Congress to advocate for sustained increases to cancer research funding

Nearly 100 ASTRO members also called on legislators to protect patient access to high quality cancer careWASHINGTON, D.C., May 25, 2016 – Radiation oncologists from across the United States convened on Capitol Hill yesterday to encourage members of Congress to invest in cancer research with sustainable and predictable funding and to protect patients’ access to high quality cancer care through value-based physician payment models. The 95 doctors were in Washington for approximately 150 meetings with Congressional leaders from their home districts and states as part of the American Society

ASTRO applauds and pledges support to President’s commitment to advancing cancer research and improving patient lives

American Society for Radiation Oncology chair ASTRO Chair Bruce D. Minsky, MD, FASTRO responds to President’s State of the Union call for progressThe American Society for Radiation Oncology (ASTRO) applauds President Obama and Vice President Biden for affirming their commitment to improving cancer patients’ lives through the “moonshot” effort in cancer research announced in the President’s State of the Union speech on Tuesday. ASTRO pledges its support of the initiative to bolster resources and foster collaboration among the oncology research community, as well as Vice President Biden’s

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media